“…A full-length tau encoding 441 amino acids is composed of a projection domain followed by a microtubule-binding domain of four repeats (labeled R1–R4) and a basic C-terminal. Tau has been shown to fibrillize in vitro in the presence of polyanionic substances. , The domain repeat R1–R4 termed K18 and spanning residues 244–368 contains two hexapeptides called PHF6* (VQIINK, residues 275–280 in R2) and PHF6 (VQIVYK, residues 306–311 in R3) that are essential for amyloid formation. , Inhibitors targeting the PHF6 motif were shown to block fibrillation. , Numerous simulations with distinct protein representations explored the conformations of tau441, , K18, K19 (which contains R1, R3 and R4 repeats), , and R1–R4 monomers, , R1–R4 and R3–R4 dimers, and the PHF6 oligomer , in a pure buffer. These simulations show that full-length tau and tau fragments do not behave as a random coil and adopt locally many transient secondary structures.…”